Triple-negative breast cancer trials recruiting in New Jersey
All Triple-negative breast cancer trials nationally
8
Recruiting in New Jersey
10
Cities with sites
Cities in New Jersey
Basking Ridge 4Middletown 4Montvale 4Hackensack 2Camden 1East Brunswick 1Flemington 1Florham Park 1New Brunswick 1Summit 1
Recruiting trials in New Jersey
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
- A Study of LY4175408 in Participants With Advanced Cancer
- A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)